MC
BIO icon

Machina Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Machina Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-618
Closed -$348K – 127
2022
Q1 		$348K Buy
+618
New +$373K 0.76% 51
2020
Q1 		– Sell
-1,160
Closed -$429K – 39
2019
Q4 		$429K Buy
1,160
+80
+7% +$28.2K 0.17% 209
2019
Q3 		$359K Buy
1,080
+136
+14% +$44.4K 0.16% 195
2019
Q2 		$295K Buy
944
+357
+61% +$107K 0.11% 214
2019
Q1 		$179K Buy
+587
New +$158K 0.07% 243

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return